Display options
Cite
Faur CI, Rotaru H, Osan C, et al. Salivary exosomal microRNAs as biomarkers for head and neck cancer detection-a literature review. Maxillofac Plast Reconstr Surg. 2021;43(1):19doi: 10.1186/s40902-021-00303-9.
Faur, C. I., Rotaru, H., Osan, C., Jurj, A., Roman, R. C., Moldovan, M., Chirila, M., & Hedesiu, M. (2021). Salivary exosomal microRNAs as biomarkers for head and neck cancer detection-a literature review. Maxillofacial plastic and reconstructive surgery, 43(1), 19. https://doi.org/10.1186/s40902-021-00303-9
Faur, Cosmin Ioan, et al. "Salivary exosomal microRNAs as biomarkers for head and neck cancer detection-a literature review." Maxillofacial plastic and reconstructive surgery vol. 43,1 (2021): 19. doi: https://doi.org/10.1186/s40902-021-00303-9
Faur CI, Rotaru H, Osan C, Jurj A, Roman RC, Moldovan M, Chirila M, Hedesiu M. Salivary exosomal microRNAs as biomarkers for head and neck cancer detection-a literature review. Maxillofac Plast Reconstr Surg. 2021 Jun 30;43(1):19. doi: 10.1186/s40902-021-00303-9. PMID: 34191144; PMCID: PMC8245637.
Copy Download .nbib Format: NLM
Share it on

Maxillofac Plast Reconstr Surg. 2021 Jun 30;43(1):19. doi: 10.1186/s40902-021-00303-9.

Salivary exosomal microRNAs as biomarkers for head and neck cancer detection-a literature review.

Maxillofacial plastic and reconstructive surgery

Cosmin Ioan Faur, Horatiu Rotaru, Ciprian Osan, Ancuta Jurj, Rares Calin Roman, Madalina Moldovan, Magdalena Chirila, Mihaela Hedesiu

Affiliations

  1. Department of Oral Radiology, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400033, Cluj-Napoca, Romania.
  2. Department of Oral and Cranio-Maxillofacial Surgery, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400033, Cluj-Napoca, Romania. [email protected].
  3. Faculty of Dental Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400033, Cluj-Napoca, Romania.
  4. Research Center for Functional Genomics, Biomedicine and Translational Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400337, Cluj-Napoca, Romania.
  5. Department of Oral and Cranio-Maxillofacial Surgery, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400033, Cluj-Napoca, Romania.
  6. Department of Otorhinolaryngology, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, 400000, Romania.

PMID: 34191144 PMCID: PMC8245637 DOI: 10.1186/s40902-021-00303-9

Abstract

BACKGROUND: MicroRNAs (miRs) are small, non-coding mRNA molecules which regulate cellular processes in tumorigenesis. miRs were discovered in extracellular environment and biological fluids, carrying marks of head and neck squamous cell carcinoma (HNSCC). They were also identified in abundance in salivary exosomes, in which they are protected by exosome lipid barrier against enzymatic injuries and therefore, the accuracy of exosomal miR-based cancer detection increase. This systematic review aimed to reveal and inventorize the most reliable exosomal miRNAs in saliva samples which can be used as novel biomarkers for early detection of HNSCC.

MATERIALS AND METHODS: A systematic literature search, according to PRISMA guideline, was performed on Pubmed and Google Academic libraries, based on specific keywords. Original articles published between 2010 and 2021 were selected. The quality of each paper was assessed using the Quality Evaluation Scoring Tool.

RESULTS: At the end of selection process, five studies met the inclusion criteria. These studies analyzed twelve salivary exosomal miRs, presenting different methods of exosome and miR identification for HNSCC detection. A comprehensive explanation of the miR pathways of action was drawn and illustrated in this review.

CONCLUSION: Exosomal miRs are promising biomarkers for oral cavity and oropharyngeal cancer detection. miR-10b-5p, miR-486-5p, miR-24-3p and miR-200a stand as the most useful ones in saliva sample examination.

Keywords: Biomarker; Exosome; Extracellular microRNA; HNSCC; Saliva

References

  1. J Biomed Opt. 2017 Oct;22(10):1-6 - PubMed
  2. Front Pharmacol. 2015 Nov 24;6:283 - PubMed
  3. Cancer Res. 2012 Jan 1;72(1):365-74 - PubMed
  4. Langmuir. 2011 Dec 6;27(23):14394-400 - PubMed
  5. Cell Prolif. 2020 Nov;53(11):e12877 - PubMed
  6. Phys Chem Chem Phys. 2011 Jun 28;13(24):11551-67 - PubMed
  7. Ann Med. 2014 Jun;46(4):221-32 - PubMed
  8. Mol Cytogenet. 2019 Jul 11;12:33 - PubMed
  9. BMC Cancer. 2018 Apr 18;18(1):439 - PubMed
  10. Methods Mol Biol. 2013;936:313-24 - PubMed
  11. J Cancer. 2018 Jan 6;9(4):638-649 - PubMed
  12. Exp Biol Med (Maywood). 2017 Mar;242(5):459-472 - PubMed
  13. Clin Cancer Res. 2009 Sep 1;15(17):5473-7 - PubMed
  14. Int J Mol Sci. 2018 Jun 08;19(6): - PubMed
  15. PLoS One. 2012;7(3):e30679 - PubMed
  16. Toxicol Appl Pharmacol. 2013 Oct 1;272(1):154-60 - PubMed
  17. CA Cancer J Clin. 2017 Mar;67(2):122-137 - PubMed
  18. Int J Mol Sci. 2019 Sep 27;20(19): - PubMed
  19. Biomed Pharmacother. 2020 Jan;121:109553 - PubMed
  20. Trends Immunol. 2014 Jul;35(7):290-8 - PubMed
  21. BMC Cancer. 2011 Feb 28;11:88 - PubMed
  22. Pancreas. 2017 Jul;46(6):782-788 - PubMed
  23. Enzymes. 2017;42:125-151 - PubMed
  24. Oral Dis. 2015 Nov;21(8):987-93 - PubMed
  25. PLoS One. 2011;6(11):e27840 - PubMed
  26. J Oral Pathol Med. 2018 Nov;47(10):954-963 - PubMed
  27. Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):5003-8 - PubMed
  28. BMJ. 2015 Jan 02;350:g7647 - PubMed
  29. Cancer. 2012 Mar 15;118(6):1693-700 - PubMed
  30. Sci Rep. 2019 Mar 29;9(1):5335 - PubMed
  31. Ann Intern Med. 2011 Oct 18;155(8):529-36 - PubMed
  32. Oncotarget. 2017 Jul 27;8(47):82459-82474 - PubMed
  33. Med Oncol. 2018 Feb 13;35(3):37 - PubMed
  34. Nat Rev Cancer. 2009 Jan;9(1):57-63 - PubMed
  35. Oncotarget. 2018 Feb 5;9(16):12868-12878 - PubMed
  36. Biomed Res Int. 2018 Nov 21;2018:9792730 - PubMed
  37. CA Cancer J Clin. 2021 May;71(3):209-249 - PubMed
  38. Semin Liver Dis. 2015 Feb;35(1):3-11 - PubMed
  39. PLoS One. 2013;8(3):e54643 - PubMed
  40. Cells. 2019 Apr 03;8(4): - PubMed
  41. Int J Cancer. 2018 Dec 1;143(11):2892-2904 - PubMed
  42. Clin Cancer Res. 2014 Dec 15;20(24):6247-53 - PubMed
  43. J Cell Biochem. 2018 May;119(5):3989-3998 - PubMed
  44. Front Physiol. 2019 Dec 10;10:1476 - PubMed
  45. Cancers (Basel). 2017 Aug 10;9(8): - PubMed
  46. Biomed Res Int. 2018 Jul 26;2018:3634563 - PubMed
  47. Clin Cancer Res. 2013 Apr 15;19(8):2154-62 - PubMed
  48. Cell Oncol (Dordr). 2014 Oct;37(5):331-8 - PubMed
  49. Future Oncol. 2016 Dec;12(23):2701-2712 - PubMed
  50. Oncotarget. 2019 Dec 31;10(68):7251-7275 - PubMed
  51. Oral Maxillofac Surg Clin North Am. 2018 Nov;30(4):381-395 - PubMed
  52. Lasers Med Sci. 2020 Aug;35(6):1393-1401 - PubMed
  53. Cancers (Basel). 2019 Jun 26;11(7): - PubMed
  54. Oncol Rep. 2017 Aug;38(2):1268-1275 - PubMed
  55. Int J Mol Med. 2016 Nov;38(5):1359-1366 - PubMed
  56. Oncol Lett. 2018 Jan;15(1):649-657 - PubMed
  57. Drug Resist Updat. 2019 Jul;45:1-12 - PubMed
  58. J Virol. 2016 Jan 13;90(7):3469-79 - PubMed
  59. BMC Cancer. 2019 Aug 28;19(1):843 - PubMed
  60. BMC Cancer. 2013 Mar 19;13:129 - PubMed
  61. Clin Chim Acta. 2020 Jan;500:226-232 - PubMed
  62. Int J Mol Sci. 2015 Sep 07;16(9):21294-309 - PubMed
  63. Cancer Res. 2011 Apr 15;71(8):3087-97 - PubMed
  64. Cells. 2020 Jan 23;9(2): - PubMed
  65. Front Immunol. 2014 Sep 24;5:464 - PubMed
  66. Nanomedicine. 2016 Aug;12(6):1593-601 - PubMed
  67. Int J Dent. 2013;2013:650218 - PubMed
  68. Mayo Clin Proc. 2016 Mar;91(3):386-96 - PubMed
  69. Sci Rep. 2015 May 14;5:9991 - PubMed

Publication Types